Fonte: Fortune
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
Fonte: Fortune
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.